Literature DB >> 24562937

Clinical implication of morphological subtypes in management of intraductal papillary mucinous neoplasm.

Suguru Yamada1, Tsutomu Fujii, Yoshie Shimoyama, Mitsuro Kanda, Goro Nakayama, Hiroyuki Sugimoto, Masahiko Koike, Shuji Nomoto, Michitaka Fujiwara, Akimasa Nakao, Yasuhiro Kodera.   

Abstract

PURPOSE: Morphological subtypes of intraductal papillary mucinous neoplasm (IPMN) have been established. Invasive IPMNs include colloid carcinoma and tubular carcinoma. Few studies have explored the association between the morphological and invasive subtypes in a large population. Clinical relevance of the morphological subtypes remains unclear.
METHODS: One hundred sixty-nine consecutive patients who underwent curative resection of IPMN were enrolled. The intraductal components were classified into four distinct epithelial subtypes: gastric, intestinal, pancreatobiliary, and oncocytic. The invasive components were classified as colloid or tubular.
RESULTS: The numbers of patients with gastric, intestinal, pancreatobiliary, and oncocytic subtypes were 123, 42, 3, and 1, respectively. Fifty-six patients had invasive cancer (tubular type, 42; colloid type, 14). The proportions of gastric type IPMN within each histological grade were 88 % among adenomas, 43 % among noninvasive carcinomas, 41 % among minimally invasive carcinomas, and 74 % among invasive carcinomas. Gastric subtype was more commonly associated with branch duct type and intestinal subtype with main duct type, and these tendencies were statistically significant (P = 0.0131). Furthermore, there was a strong correlation between gastric and tubular types and between intestinal and colloid types (P < 0.0001). The 5-year survival rate among the 56 invasive cancers was 52.7 % for gastric type and 89.7 % for intestinal type, which was statistically significant (P = 0.030).
CONCLUSIONS: Gastric type IPMN is mostly derived from branch duct IPMN and often demonstrates benign behavior, as seen with adenomas. However, once gastric type IPMN develops into invasive carcinoma, the survival rate is significantly lower than other types.

Entities:  

Mesh:

Year:  2014        PMID: 24562937     DOI: 10.1245/s10434-014-3565-1

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  12 in total

Review 1.  Clinical approach to incidental pancreatic cysts.

Authors:  Austin L Chiang; Linda S Lee
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

2.  Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting.

Authors:  Volkan Adsay; Mari Mino-Kenudson; Toru Furukawa; Olca Basturk; Giuseppe Zamboni; Giovanni Marchegiani; Claudio Bassi; Roberto Salvia; Giuseppe Malleo; Salvatore Paiella; Christopher L Wolfgang; Hanno Matthaei; G Johan Offerhaus; Mustapha Adham; Marco J Bruno; Michelle D Reid; Alyssa Krasinskas; Günter Klöppel; Nobuyuki Ohike; Takuma Tajiri; Kee-Taek Jang; Juan Carlos Roa; Peter Allen; Carlos Fernández-del Castillo; Jin-Young Jang; David S Klimstra; Ralph H Hruban
Journal:  Ann Surg       Date:  2016-01       Impact factor: 12.969

Review 3.  Liver and Pancreas: Do Similar Embryonic Development and Tissue Organization Lead to Similar Mechanisms of Tumorigenesis?

Authors:  Elsa Ghurburrun; Ivan Borbath; Frédéric P Lemaigre; Patrick Jacquemin
Journal:  Gene Expr       Date:  2018-03-26

4.  Prognosis of resected intraductal papillary mucinous neoplasm of the pancreas: using revised 2017 international consensus guidelines.

Authors:  Ji Hye Min; Young Kon Kim; Honsoul Kim; Dong Lk Cha; Soohyun Ahn
Journal:  Abdom Radiol (NY)       Date:  2020-06-24

5.  Interobserver variability in intraductal papillary mucinous neoplasm subtypes and application of their mucin immunoprofiles.

Authors:  Heewon A Kwak; Xiuli Liu; Daniela S Allende; Rish K Pai; John Hart; Shu-Yuan Xiao
Journal:  Mod Pathol       Date:  2016-05-20       Impact factor: 7.842

Review 6.  Pancreatic cystic neoplasms: Review of current knowledge, diagnostic challenges, and management options.

Authors:  Tanima Jana; Jennifer Shroff; Manoop S Bhutani
Journal:  J Carcinog       Date:  2015-03-14

7.  Diversity of Precursor Lesions For Pancreatic Cancer: The Genetics and Biology of Intraductal Papillary Mucinous Neoplasm.

Authors:  Krushna C Patra; Nabeel Bardeesy; Yusuke Mizukami
Journal:  Clin Transl Gastroenterol       Date:  2017-04-06       Impact factor: 4.488

Review 8.  Intraductal Papillary Mucinous Adenocarcinoma of the Pancreas: Clinical Outcomes, Prognostic Factors, and the Role of Adjuvant Therapy.

Authors:  Zhi Ven Fong; Carlos Fernández-Del Castillo
Journal:  Viszeralmedizin       Date:  2015-02

Review 9.  The Clinical and Socio-Economic Relevance of Increased IPMN Detection Rates and Management Choices.

Authors:  Christoph Budde; Georg Beyer; Jens-Peter Kühn; Markus M Lerch; Julia Mayerle
Journal:  Viszeralmedizin       Date:  2015-02

Review 10.  Comparison of guidelines for intraductal papillary mucinous neoplasm: What is the next step beyond the current guidelines?

Authors:  Masafumi Nakamura; Yoshihiro Miyasaka; Yoshihiko Sadakari; Kenjiro Date; Takao Ohtsuka
Journal:  Ann Gastroenterol Surg       Date:  2017-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.